Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease. (2016).
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic. (2014).

Cannabinoids for the treatment of dementia. (2009).

Author(s): Krishnan S., Cairns R., Howard R.

Cannabinoids may have more positive and specific effects on the disruption of the disease process in Alzheimer’s disease. View study